Trial Profile
An Open-label, Multi-centre, Multi-national Post-marketing Non-interventional Observational Study of the Use of Zonisamide (ZNS) in the Adjunctive Treatment of Adult Patients With Partial Onset Seizures Treated With One Antiepileptic Drug (AED) as Baseline Medication
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2018
Price :
$35
*
At a glance
- Drugs Zonisamide (Primary)
- Indications Seizures
- Focus Therapeutic Use
- Acronyms ZOOM
- Sponsors Eisai Inc
- 25 Apr 2013 New trial record